drugset / Trial / NCT04851717

Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures

NCT04851717

Phase 2/3 Active not recruiting 100 enrolled Acacia Pharma Ltd Paion UK Ltd. · collab
NaSingle-groupOpen-labelSupportive care

Summary

To assess the efficacy of intravenous remimazolam in inducing and maintaining suitable sedation levels for paediatric patients undergoing diagnostic and/or therapeutic procedures

Timeline

Start
2021-11-15
Primary completion
2027-10
Completion
2027-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Remimazolam Small molecule Intravenous